Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1979-01-08
1981-05-19
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
128659, 260112R, 424 15, 424 9, A61K 2900, G01N 3348
Patent
active
042684951
ABSTRACT:
An injectable embolization and occlusion solution for the selective closure of organs, their duct systems, or blood vessels, comprises a solution of a prolamine such as zein in a physiologically compatible solvent such as ethanol. The solution is injected into the site to be treated where the prolamine quickly precipitates in the body fluids to occlude the site area.
REFERENCES:
Mosse, Chem. Abstracts, vol. 66, 1967, abstract number 8283g.
Bonadeo, Chem. Abstracts, vol. 72, 1970, abstract number 88767a.
Ikegami et al, Chem. Abstracts, vol. 84, 1976, abstract number 104185q.
Thelen et al, Forschr. Rontgenstr., 124(3), 1976, pp. 232-235.
Dahlke Hermann
Muxfeldt Hans
Eberhardt Wayne R.
Ethicon Inc.
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Injectable embolization and occlusion solution does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Injectable embolization and occlusion solution, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injectable embolization and occlusion solution will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1489446